The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.
Blockade of the renin-angiotensin-aldosterone system exhibits a renoprotective effect; however, blockade of this system may also decrease hemoglobin (Hb) and erythropoietin (EPO) levels. We evaluated the correlation between reduced albuminuria and decreased hemoglobin concentrations after treatment...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4476682?pdf=render |
| _version_ | 1818136196051632128 |
|---|---|
| author | Jung Nam An Jin Ho Hwang Jung Pyo Lee Ho Jun Chin Sejoong Kim Dong Ki Kim Suhnggwon Kim Jung Hwan Park Sung Joon Shin Sang Ho Lee Bum Soon Choi Chun Soo Lim |
| author_facet | Jung Nam An Jin Ho Hwang Jung Pyo Lee Ho Jun Chin Sejoong Kim Dong Ki Kim Suhnggwon Kim Jung Hwan Park Sung Joon Shin Sang Ho Lee Bum Soon Choi Chun Soo Lim |
| author_sort | Jung Nam An |
| collection | DOAJ |
| description | Blockade of the renin-angiotensin-aldosterone system exhibits a renoprotective effect; however, blockade of this system may also decrease hemoglobin (Hb) and erythropoietin (EPO) levels. We evaluated the correlation between reduced albuminuria and decreased hemoglobin concentrations after treatment with an angiotensin II receptor blocker (ARB). Two hundred forty-five non-diabetic hypertensive participants with established albuminuria and relatively preserved renal function were treated with an ARB (40 mg/day olmesartan) for eight weeks. Subsequent changes in various clinical parameters, including Hb, EPO, and albuminuria, were analyzed following treatment. After the 8-week treatment with an ARB, Hb and EPO levels significantly decreased. Patients with a greater decrease in Hb exhibited a greater reduction in 24-hour urinary albumin excretion compared with patients with less of a decrease or no decrease in Hb, whereas no associations with a decline in renal function and EPO levels were noted. Multivariate logistic regression analysis demonstrated a correlation between the reduction of urine albumin excretion and the decrease in Hb levels (after natural logarithm transformation, adjusted odds ratio 1.76, 95% confidence interval 1.21-2.56, P = 0.003). Linear regression analysis also supported this positive correlation (Pearson correlation analysis; R = 0.24, P < 0.001). Decreased Hb concentrations following ARB treatment were positively correlated with reduced albuminuria in non-diabetic hypertensive patients, regardless of decreased blood pressure and EPO levels or renal function decline. |
| first_indexed | 2024-12-11T09:36:33Z |
| format | Article |
| id | doaj.art-a4c0115a0e47445dacb731efef2654a4 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T09:36:33Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-a4c0115a0e47445dacb731efef2654a42022-12-22T01:12:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01106e012863210.1371/journal.pone.0128632The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.Jung Nam AnJin Ho HwangJung Pyo LeeHo Jun ChinSejoong KimDong Ki KimSuhnggwon KimJung Hwan ParkSung Joon ShinSang Ho LeeBum Soon ChoiChun Soo LimBlockade of the renin-angiotensin-aldosterone system exhibits a renoprotective effect; however, blockade of this system may also decrease hemoglobin (Hb) and erythropoietin (EPO) levels. We evaluated the correlation between reduced albuminuria and decreased hemoglobin concentrations after treatment with an angiotensin II receptor blocker (ARB). Two hundred forty-five non-diabetic hypertensive participants with established albuminuria and relatively preserved renal function were treated with an ARB (40 mg/day olmesartan) for eight weeks. Subsequent changes in various clinical parameters, including Hb, EPO, and albuminuria, were analyzed following treatment. After the 8-week treatment with an ARB, Hb and EPO levels significantly decreased. Patients with a greater decrease in Hb exhibited a greater reduction in 24-hour urinary albumin excretion compared with patients with less of a decrease or no decrease in Hb, whereas no associations with a decline in renal function and EPO levels were noted. Multivariate logistic regression analysis demonstrated a correlation between the reduction of urine albumin excretion and the decrease in Hb levels (after natural logarithm transformation, adjusted odds ratio 1.76, 95% confidence interval 1.21-2.56, P = 0.003). Linear regression analysis also supported this positive correlation (Pearson correlation analysis; R = 0.24, P < 0.001). Decreased Hb concentrations following ARB treatment were positively correlated with reduced albuminuria in non-diabetic hypertensive patients, regardless of decreased blood pressure and EPO levels or renal function decline.http://europepmc.org/articles/PMC4476682?pdf=render |
| spellingShingle | Jung Nam An Jin Ho Hwang Jung Pyo Lee Ho Jun Chin Sejoong Kim Dong Ki Kim Suhnggwon Kim Jung Hwan Park Sung Joon Shin Sang Ho Lee Bum Soon Choi Chun Soo Lim The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial. PLoS ONE |
| title | The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial. |
| title_full | The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial. |
| title_fullStr | The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial. |
| title_full_unstemmed | The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial. |
| title_short | The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial. |
| title_sort | decrement of hemoglobin concentration with angiotensin ii receptor blocker treatment is correlated with the reduction of albuminuria in non diabetic hypertensive patients post hoc analysis of especial trial |
| url | http://europepmc.org/articles/PMC4476682?pdf=render |
| work_keys_str_mv | AT jungnaman thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT jinhohwang thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT jungpyolee thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT hojunchin thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT sejoongkim thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT dongkikim thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT suhnggwonkim thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT junghwanpark thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT sungjoonshin thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT sangholee thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT bumsoonchoi thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT chunsoolim thedecrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT jungnaman decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT jinhohwang decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT jungpyolee decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT hojunchin decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT sejoongkim decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT dongkikim decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT suhnggwonkim decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT junghwanpark decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT sungjoonshin decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT sangholee decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT bumsoonchoi decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial AT chunsoolim decrementofhemoglobinconcentrationwithangiotensiniireceptorblockertreatmentiscorrelatedwiththereductionofalbuminuriainnondiabetichypertensivepatientsposthocanalysisofespecialtrial |